5 insights for commercial teams on the strategic value of biomarker data

Skip to content
Skip to footer

Oncology Data for Commercial & Brand ON.ClinicalDataView ON.Insights Alerts

Oncology Data for HEOR & Research ON.OutcomesView ON.JourneyView

Oncology Data for Clinical Development

Real-world Research

Ontada's research expertise covers the entire process, from proposal to publication, with clinical support from practicing oncologists acting as principal investigators, research support from Ontada's Medical Office, and researchers with over 400+ real-world publication contributions

Ontada Learn Digital Education Meetings & Events Practice-based Education Strategy & Effectiveness

Cancer care usually happens outside of experimental settings, but patient genomic data isn't commonly used to make decisions. Genospace uses patient data from next-generation sequencing to create market reports. Real-world evidence is vital to understanding genomics in cancer progression and therapeutic interaction.

Join Ontada at oncology conferences across the country to see how our data, research, and provider education solutions can help your company advance cancer care

Keep yourself informed about the most recent news and announcements from Ontada. Discover the latest developments in oncology research and healthcare solutions.

Our thought leaders share expertise, research, and insights in top oncology publications. Join us to stay updated on cancer care advancements.

Explore curated oncology resources that support strategy development in real-world data, provider engagement and real-world research.

Ontada, whose name is a combination of “oncology” and “data,” was formed with the vision that transforming cancer care requires speed. Our commitment is to provide the most current evidence in oncology treatment so insights can be generated faster.

Leadership Team

Ontada is on a mission to transform cancer care and improve the lives of patients, setting new standards in the integration of research and clinical practice to generate real-world data, insights and evidence. Meet our team leading the way.

We need smart, ambitious and empathetic people to help us build the future of cancer treatment. Join us on the frontline of oncology innovation.

5 insights for commercial teams on the strategic value of biomarker data

A biomarker result can seem simple: positive or negative. But commercial strategy depends on what lies beneath that label. Molecular context determines whether an opportunity is real, inflated or overlooked.

Our new white paper, “5 insights for commercial teams on the strategic value of biomarker data,” explores how deeper biomarker insight can impact commercial strategy. Whether it’s sharpening market sizing, aligning with therapeutic relevance or reducing costly missteps, these insights can help commercial teams navigate complex oncology decisions.

Inside the paper, you’ll learn how to:

Make projections with molecular-level clarity
Use granular data to refine segmentation and uncover underserved populations
Harmonize data across sources for accurate patient counts and stronger feasibility models

Download the white paper today and see how biomarker precision can drive smarter strategy.

top